Form 4: SpartanNash Director Dorlisa K. Flur Awarded Restricted Stock Units
SEC Form 4
Director Dorlisa K. Flur received 7,847 Restricted Stock Units (RSUs) under the SpartanNash Company 2024 Stock Incentive Plan.
Summary
- Dorlisa K. Flur, a director of SpartanNash Co, was granted 7,847 Restricted Stock Units (RSUs) on March 11, 2025.
- The RSUs were awarded under the SpartanNash Company 2024 Stock Incentive Plan.
- These RSUs will vest on March 15, 2026, and each RSU represents the right to receive one share of SpartanNash common stock upon vesting.
- Prior to vesting, the RSUs are subject to restrictions according to the Plan's terms.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The granting of RSUs is a standard practice and generally viewed as a positive incentive for management.
Positives
- The award of RSUs aligns the director's interests with those of the shareholders, incentivizing performance and long-term value creation.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
This is a routine disclosure related to executive compensation and is common practice for publicly traded companies.
Stakeholder Impact
- Shareholders may view the RSU grant as a positive incentive for the director to increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| July 26, 2024 | Date of Power of Attorney granted by Dorlisa K. Flur. |
| March 11, 2025 | Date of transaction: Dorlisa K. Flur acquired 7,847 Restricted Stock Units. |
| March 13, 2025 | Date of Form 4 signature. |
| March 15, 2026 | Vesting date for the Restricted Stock Units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.